泰格医药2025年净利8.88亿元，同比增长119.15%

Core Viewpoint - Tiger Medical reported a revenue of 6.833 billion yuan for 2025, marking a year-on-year growth of 3.48%, while net profit attributable to shareholders reached 888 million yuan, reflecting a significant increase of 119.15% [1] Financial Performance - The company achieved a revenue of 6.833 billion yuan in 2025, which is a 3.48% increase compared to the previous year [1] - The net profit attributable to shareholders was 888 million yuan, showing a remarkable growth of 119.15% year-on-year [1] Order Demand and Contracts - During the reporting period, the company's order demand accelerated, with net new orders amounting to 10.16 billion yuan, representing a year-on-year increase of 20.7% [1] - The average price of new orders stabilized in 2025, with expectations of returning to a growth trend in 2026 [1] - As of the end of the reporting period, the total amount of contracts to be executed reached 18.2 billion yuan, which is a 15.3% increase compared to the previous year [1]